Accueil   Diary - News   All news DIABELOOP

DIABELOOP

logo_diabeloop

Diabeloop, lyonbiopole member company, created an artificial pancreas "Made in France " that can change the lives of these patients in the near future. This new device , which helps regulate blood glucose instead of the failing pancreas, will improve the treatment significantly, reduce the daily burden of disease, prevent complications (blindness, amputations, acute renal failure ) and avoid 1 000 deaths per year .

 

Mesure de son taux de glycémie 4 à 6 fois par jours, injections multiples d’insuline, calibrage de l’alimentation et de l’activité physique pour décider de la dose d’insuline, hantise de l’hypoglycémie permanente ou des complications du diabète… Voici le quotidien difficile de 200 000 malades en France atteint du diabète de type 1, dont 50% ont déclaré la maladie avant l’âge de 20 ans.

 

Measuring his blood sugar 4-6 times a day, multiple insulin injections, power and calibration of physical activity to decide insulin dose, fear of permanent hypoglycemia or diabetes complications ... Here the troubled lives of 200,000 patients in France with type 1 diabetes, 50 % said the disease before age 20 years.

 

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree